Evidence map›Paper›PMID 40852466›Full record

ArticleAccess microbiology2025

Potential role of gut bacteria in the development of hepatocellular carcinoma.

Bingqing Yan, Yuchao Wang, Ziqi Wang, Ailong Huang, Xiuxiu Jin, Tiantian Jiang, Hong Xue, Zheyu Shen, Shifang Wang, Haiyan Xu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Access microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bingqing YanNantong Center for Disease Control and Prevention, Nantong, PR China.
Yuchao WangNantong Center for Disease Control and Prevention, Nantong, PR China.
Ziqi WangNantong Third People's Hospital, Nantong, PR China.
Ailong HuangNantong Center for Disease Control and Prevention, Nantong, PR China.
Xiuxiu JinNantong Center for Disease Control and Prevention, Nantong, PR China.
Tiantian JiangNantong Center for Disease Control and Prevention, Nantong, PR China.
Hong XueNantong Third People's Hospital, Nantong, PR China.
Zheyu ShenNantong Third People's Hospital, Nantong, PR China.
Shifang WangNantong Center for Disease Control and Prevention, Nantong, PR China.
Haiyan XuNantong Center for Disease Control and Prevention, Nantong, PR China.
Renfei ZhuNantong Third People's Hospital, Nantong, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cancer is the fourth most deadly cancer, and early detection and timely treatment apparently play a crucial role in it. Intestinal bacteria affect the development of liver cancer through various pathways. In this study, the gut bacteria of liver cancer patients are analysed in detail by using metagenomic sequencing technology, and some of the bacterial species and metabolic pathways that may affect the development of liver cancer have been identified. Additionally, we identified bacterial factors that may impact key clinical indicators of the tumour. The findings of this study provide a scientific foundation for understanding the mechanisms underlying liver cancer development. This study freshened insights into clinical treatment strategies for liver cancer.

Indexed as

gut bacterialiver cancermetagenomepathway

Identifiers

PMID40852466
PMCPMC12369552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.